- Research
Our congratulations to Drs. David Birnie and George Wells, on behalf of the OCEAN Investigators, winners of UOHI’s 2025 Dr Robert Roberts Publication of the Year Award
The OCEAN trial, a groundbreaking international study co-led by the University of Ottawa Heart Institute and McGill University Health Centre, provides the first evidence to address one of the most important clinical questions in modern electrophysiology
- Research
Our congratulations to Dr. Jennifer Reed, winner of UOHI’s 2025 Global Impact Award
Dr. Reed is an internationally-recognized expert in the field of cardiovascular prevention and rehabilitation, putting UOHI on the global map as a leader in exercise interventions in cardiovascular disease prevention and rehabilitation.
- Research
Our congratulations to Dr. Derek So, winner of UOHI’s 2025 Global Impact Award
Dr. So’s sustained research and leadership in interventional cardiology have driven exceptional impact in cardiovascular medicine across Canada and internationally.
- Research
Our congratulations to Dr. David Messika-Zeitoun, UOHI’s 2025 Investigator of the Year
Dr. Messika-Zeitoun is an outstanding clinician-investigator who is making an indelible mark for uOttawa, the Heart Institute, and Canada for his novel insights into the pathophysiology and management of Valvular Heart Disease (VHD).
- Research
Gut molecule discovered that may help protect against type 2 diabetes
As diabetes affects hundreds of millions of people globally, the discovery offers promising new paths for treatment
- Research
Our congratulations to Dr. Darryl Davis, winner of UOHI’s 2025 Research Innovation Award
Dr. Darryl Davis is recognized for his bold creativity and original thinking in cardiovascular research and innovation
- Research
The 2025 Research Infosource rankings highlight the strength of research and innovation in Ottawa
The Ottawa Hospital / University of Ottawa Heart Institute ranked as the top research hospital in Ottawa and among the top 10 in Canada for combined research activity in 2023-24.
- Research
Landmark Canadian-led trial finds many atrial fibrillation patients can stop taking blood thinners
A new trial co-led by the Ottawa Heart Institute and the Research Institute of the McGill University Health Centre shows that continuing these medications offers no added protection against stroke or embolic events compared with low-dose aspirin
- Research
Heart Institute scientist advises on national report on research security and open science
Report explores how Canada can protect sensitive research while continuing to support innovation and open science
- Research
Heart Institute researchers to advance studies in grief, heart remodelling, genetics and inflammation
The Grant-in-Aid Program provides operating support for important, innovative research in heart disease and stroke